Cancer Genetics Inc (NASDAQ:CGIX)

7.61
Delayed Data
As of 1:23pm ET
 -0.37 / -4.64%
Today’s Change
4.83
Today|||52-Week Range
16.88
+13.92%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$78.4M

Company Description

Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays, and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Information

Cancer Genetics, Inc.
Meadows Office Complex
Rutherford New Jersey 07070
P:(201) 528-9200
Investor Relations:

Employees

Shareholders

Other institutional6.61%
Individual stakeholders22.09%
Mutual fund holders12.50%

Top Executives

Panna L. SharmaPresident, Chief Executive Officer & Director
Robert FannonVice President-Operations
Edward J. SitarChief Financial Officer, Secretary & Treasurer
Jane Houldsworth El NaggarVice President-Research & Development
Weiyi ChenDirector-Molecular Diagnostics

To view my watchlist

Not a member yet?

Sign up now for a free account